Study finds cancer cells can adapt to novel drugs

Researchers found cancer cells can adapt to new drugs called CDK2 inhibitors in 1-2 hours, adding that a second drug squelches the workaround. According to new CU Boulder research, cancer cells are smarter than scientists previously thought. When these cells are confronted with powerful new drugs known as CDK2 inhibitors, which are designed to prevent cancer from spreading, they can activate a workaround that allows them to survive the attack in as little as one to two hours.